Overall, our pilot study provides an excellent starting point for further studies investigating larger number of ALK rearranged lung cancer patients, as well as for proteomic and GAG-omic characterization of other gene rearrangements causing adenocarcinoma. The gene discussed is ALK; the disease is lung carcinoma.